About Harbour Antibodies

What does Harbour Antibodies do?

Harbour Antibodies is a provider of transgenic mouse technology for engineering mice to produce high affinity human antibodies. Established in 2006, leveraging technology developed in the laboratory of Professor Frank Grosveld at Erasmus MC (Rotterdam, the Netherlands). The company has developed two types of human immunoglobulin gene transgenic mice.

Who are Harbour Antibodies's competitors?

Harbour Antibodies's competitors and similar companies include RedShift BioAnalytics, Signal Pharmaceuticals, Akonni Biosystems, Sartorius, and Microbix.

Where is Harbour Antibodies headquartered?

Harbour Antibodies is headquartered in United States.

How many employees does Harbour Antibodies have?

Harbour Antibodies has 1,000 employees 🔒.

When was Harbour Antibodies founded?

Harbour Antibodies was founded in 2010 🔒.

What sector and industry vertical is Harbour Antibodies in?

Harbour Antibodies is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Harbour Antibodies

Who are the top strategic acquirers in Harbour Antibodies's sector and industry

Top strategic M&A buyers and acquirers in Harbour Antibodies's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Harbour Antibodies?

Top strategic M&A buyers groups and sectors for Harbour Antibodies include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Harbour Antibodies's sector and industry vertical

Which are the top PE firms investing in Harbour Antibodies's sector and industry vertical?

Top PE firms investing in Harbour Antibodies's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Harbour Antibodies's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Harbour Antibodies's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Harbour Antibodies's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Harbour Antibodies include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Harbour Antibodies's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Harbour Antibodies?

The key public trading comparables and valuation benchmarks for Harbour Antibodies include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Harbour Antibodies for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Harbour Antibodies with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Harbour Antibodies's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Harbour Antibodies with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Harbour Antibodies's' sector and industry vertical?

Access recent funding rounds and capital raises in Harbour Antibodies's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.